Document Detail


Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD.
MedLine Citation:
PMID:  10992537     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Enzymatic and histochemical abnormalities of the peripheral muscle may play a role in exercise intolerance in patients with chronic obstructive pulmonary disease (COPD). A study was undertaken to measure the mitochondrial enzyme activity of the vastus lateralis muscle in patients with COPD and to evaluate the relationship between enzyme activities and functional status. METHODS: Fifty seven patients with COPD of mean (SD) age 66 (7) years with forced expiratory volume in one second (FEV(1)) 39 (15)% predicted and peak oxygen uptake (VO(2)) of 14 (4) ml/min/kg and 15 normal subjects of similar age were included in the study. Each subject performed a stepwise exercise test up to maximal capacity during which five-breath averages of VO(2) were measured. Muscle specimens were obtained by percutaneous needle biopsy of the vastus lateralis muscle and the activity of two mitochondrial enzymes (citrate synthase (CS) and 3-hydroxyacyl CoA dehydrogenase (HADH)) was measured. The functional status of the patients was classified according to peak VO(2). RESULTS: CS and HADH activities were markedly reduced in patients with COPD compared with normal subjects (22.3 (2.7) versus 29.5 (7.3) micromol/min/g muscle (p<0.0001) and 5. 1 (2.0) versus 6.7 (1.9) micromol/min/g muscle (p<0.005), respectively). The activity of CS decreased progressively with the deterioration in the functional status while that of HADH was not related to functional status. Using a stepwise regression analysis, percentage predicted functional residual capacity (FRC), the activity of CS, oxygen desaturation during exercise, age, and inspiratory capacity (% pred) were found to be significant determinants of peak VO(2). The regression model explained 59% of the variance in peak VO(2) (p<0.0001). CONCLUSIONS: The oxidative capacity of the vastus lateralis muscle is reduced in patients with moderate to severe COPD compared with normal subjects of similar age. In these individuals the activity of CS correlated significantly with peak exercise capacity and independently of lung function impairment.
Authors:
F Maltais; P LeBlanc; F Whittom; C Simard; K Marquis; M Bélanger; M J Breton; J Jobin
Related Documents :
19567487 - Effects of unsupported upper extremity exercise training in patients with copd: a rando...
8555987 - Effects of almitrine on the ventilatory control, breathing pattern and maximal exercise...
11371407 - Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance ...
18403667 - Are patients with copd more active after pulmonary rehabilitation?
15133427 - Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic...
8401937 - Protection by nicorandil against the dysfunction of the central vagal baroreflex system...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Thorax     Volume:  55     ISSN:  0040-6376     ISO Abbreviation:  Thorax     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-23     Completed Date:  2000-10-23     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0417353     Medline TA:  Thorax     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  848-53     Citation Subset:  IM    
Affiliation:
Centre de recherche, Hôpital Laval, Institut Universtaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
3-Hydroxyacyl CoA Dehydrogenases / metabolism*
Aged
Citrate (si)-Synthase / metabolism*
Exercise / physiology
Exercise Tolerance / physiology
Female
Forced Expiratory Volume / physiology
Humans
Lung Diseases, Obstructive / enzymology*,  physiopathology
Male
Middle Aged
Muscle, Skeletal / enzymology*
Oxygen Consumption / physiology*
Vital Capacity / physiology
Chemical
Reg. No./Substance:
EC 1.1.1.35/3-Hydroxyacyl CoA Dehydrogenases; EC 2.3.3.1/Citrate (si)-Synthase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic ast...
Next Document:  Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients.